CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Format: Artigo
Idioma:Russo
Publicat: IRBIS LLC 2016-02-01
Col·lecció:Фармакоэкономика
Matèries:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Accés en línia:https://www.pharmacoeconomics.ru/jour/article/view/130
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars